EIM
BLUE

Essex Investment Management’s bluebird bio BLUE Stock Holding History

Essex Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-337
Closed -$687K – 482
2019
Q1 		$687K Buy
+337
New +$593K 0.1% 236
2016
Q1 		– Sell
-1,258
Closed -$1.05M – 316
2015
Q4 		$1.05M Sell
1,258
-13
-1% -$13K 0.16% 144
2015
Q3 		$1.41M Hold
1,271
– – 0.23% 101
2015
Q2 		$2.77M Buy
1,271
+733
+136% +$1.49M 0.42% 63
2015
Q1 		$842K Buy
538
+196
+57% +$259K 0.12% 177
2014
Q4 		$406K Buy
+342
New +$229K 0.06% 249

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's BLUE Position: Q2 2019 in Review

Essex Investment Management sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 337 shares — an estimated $687K sold.

Essex Investment Management first reported a position in BLUE in Q4 2014 and held it in 6 quarters. The position peaked at $2.77M in Q2 2015. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Essex Investment Management reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Essex Investment Management sold 337 bluebird bio shares in Q2 2019, an estimated $687K.
  • Essex Investment Management first reported a position in bluebird bio in Q4 2014 and held it in 6 quarters.
  • Essex Investment Management's bluebird bio position peaked at $2.77M in Q2 2015.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Essex Investment Management's 13F filing for Q2 2019, filed 15 Aug 2019.